Cargando…
Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma
epatocellular carcinoma (HCC) is one of the leading contributors to cancer mortality worldwide. Currently, the prevention and treatment of HCC remains a major challenge. As a traditional Chinese medicine (TCM) formula, Ruangan Lidan decoction (RGLD) has been proved to own the effect of relieving HCC...
Autores principales: | Chen, Cuilan, Liang, Ting, Wu, Qihui, Zhou, Zheyi, Zhang, Mingmin, Feng, Dongshan, Tao, Jingrui, Si, Tao, Cai, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791079/ https://www.ncbi.nlm.nih.gov/pubmed/36578460 http://dx.doi.org/10.1155/2022/2940654 |
Ejemplares similares
-
Ruangan Lidan decoction inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregulating PDK4
por: Si, Tao, et al.
Publicado: (2023) -
Systematically Characterizing Chemical Profile and Potential Mechanisms of Qingre Lidan Decoction Acting on Cholelithiasis by Integrating UHPLC-QTOF-MS and Network Target Analysis
por: Huang, Peng, et al.
Publicado: (2019) -
Anti-Liver Fibrosis Activity and the Potential Mode of Action of Ruangan Granules: Integrated Network Pharmacology and Metabolomics
por: Shang, Xiaofei, et al.
Publicado: (2022) -
Prevention of gallstones by Lidan Granule: Insight into underlying mechanisms using a guinea pig model
por: WU, XIAO, et al.
Publicado: (2016) -
Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients
por: Jiang, Ting-Ting, et al.
Publicado: (2021)